Daridorexant, Idorsia’s dual orexin receptor antagonist, shows consistent efficacy across both insomnia- and nocturia-related endpoints in a placebo-controlled study in patients with chronic insomnia ...

Daridorexant, Idorsia's dual orexin receptor antagonist, shows consistent efficacy across both insomnia- and nocturia-related endpoints in a placebo-controlled study in patients with chronic insomnia ...

The study, named A randomized cross-over trial of daridorexant for the treatment of chronic insomnia and nocturia, is a ...

At its March meeting, the European Medicines Agency’s management board adopted the EMA’s annual report for 2024. This ...

L&T Finance Ltd., incorporated in the year 2008, is a Large Cap company (having a market cap of Rs 34,877.37 Crore) operating in NBFC sector. L&T Finance Ltd. key Products/Revenue Segments include ...